Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Non Operating Interest Expenses (2009 - 2026)

Revvity's (RVTY) quarterly Non Operating Interest Expenses came in at $25.8 million in Q3 2026, up 16.62% on a YoY basis from $22.1 million in Q3 2025, and little changed quarter-over-quarter from $25.9 million in Q2 2026.

Analysis

Revvity (RVTY) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Non Operating Interest Expenses for 13 consecutive years, with $25.8 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Non Operating Interest Expenses rose 16.62% year-over-year to $25.8 million; the trailing twelve-month figure through Jul 2026 stood at $98.1 million (up 53.38% YoY), and the FY2025 full-year result was $88.4 million, up 188.61% from the prior year.
  • Non Operating Interest Expenses was little changed at $25.8 million in Q3 2026 per RVTY's latest filing, from $25.9 million in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at $46.7 million in Q2 2023 and bottomed at -$2.2 million in Q3 2024.
  • Historically, Non Operating Interest Expenses has averaged $23.1 million across 5 years, with a median of $25.0 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses slumped 114.43% in 2024, then jumped 2457.14% in 2025.
  • Over 5 years, Non Operating Interest Expenses stood at $28.6 million in 2022, then surged by 59.86% to $45.8 million in 2023, then sank by 47.16% to $24.2 million in 2024, then decreased by 16.55% to $20.2 million in 2025, then grew by 27.72% to $25.8 million in 2026.
  • According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $25.8 million, $25.9 million, and $20.2 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 401.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 107.00 Mn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 29.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 24.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 25.79 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 2.12 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 12.10 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 5.66 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 17.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 25.79 Mn
Apr 5, 2026 25.89 Mn
Dec 28, 2025 20.19 Mn
Sep 28, 2025 26.21 Mn
Jun 29, 2025 22.11 Mn
Mar 30, 2025 19.85 Mn
Dec 29, 2024 24.19 Mn
Sep 29, 2024 -2.21 Mn
Jun 30, 2024 -938,000.00
Mar 31, 2024 9.57 Mn
Dec 31, 2023 45.78 Mn
Oct 1, 2023 18.63 Mn
Jul 2, 2023 6.50 Mn
Apr 2, 2023 46.68 Mn
Jan 1, 2023 36.13 Mn
Oct 2, 2022 28.64 Mn
Jul 3, 2022 26.15 Mn
Apr 3, 2022 37.05 Mn
Oct 3, 2021 60.55 Mn
Jul 4, 2021 6.43 Mn